Bioequivalence and safety of entecavir tablets in healthy Chinese subjects
ObjectiveTo investigate the bioequivalence and safety of the generic drug entecavir versus the original drug entecavir tablets in healthy Chinese subjects. MethodsA randomized, open, two-cycle, two-cross, fasting trial was designed and performed for 28 healthy subjects, and the subjects were given s...
Main Author: | LIU Zhengzhi |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2020-12-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=11232 |
Similar Items
-
Bioequivalence and safety of sofosbuvir tablets in the healthy Chinese subjects
by: LIU Guangwen
Published: (2020-12-01) -
Pharmacokinetics, Bioequivalence and Safety Evaluation of Two Ticagrelor Tablets Under Fasting and Fed Conditions in Healthy Chinese Subjects
by: Wang J, et al.
Published: (2021-03-01) -
Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects
by: Jaafar J. Ibraheem Al-Tamimi
Published: (2017-03-01) -
Bioequivalence and Pharmacokinetics of Two Formulations of Amlodipine Tablets in Healthy Subjects
by: Jaafar J. Ibraheem Al-Tamimi
Published: (2017-03-01) -
Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
by: Xin Li, et al.
Published: (2020-11-01)